165 related articles for article (PubMed ID: 3519607)
1. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes.
Cara JF; Nakagawa SH; Tager HS
Endocrinology; 1988 Jun; 122(6):2881-7. PubMed ID: 2967179
[TBL] [Abstract][Full Text] [Related]
3. Role of the COOH-terminal B-chain domain in insulin-receptor interactions. Identification of perturbations involving the insulin mainchain.
Nakagawa SH; Tager HS
J Biol Chem; 1987 Sep; 262(25):12054-8. PubMed ID: 3305501
[TBL] [Abstract][Full Text] [Related]
4. Disposition of the phenylalanine B25 side chain during insulin-receptor and insulin-insulin interactions.
Mirmira RG; Tager HS
Biochemistry; 1991 Aug; 30(33):8222-9. PubMed ID: 1868095
[TBL] [Abstract][Full Text] [Related]
5. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions.
Mirmira RG; Nakagawa SH; Tager HS
J Biol Chem; 1991 Jan; 266(3):1428-36. PubMed ID: 1988428
[TBL] [Abstract][Full Text] [Related]
6. Role of the phenylalanine B24 side chain in directing insulin interaction with its receptor. Importance of main chain conformation.
Mirmira RG; Tager HS
J Biol Chem; 1989 Apr; 264(11):6349-54. PubMed ID: 2649499
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
8. Cross-linking of a B25 azidophenylalanine insulin derivative to the carboxyl-terminal region of the alpha-subunit of the insulin receptor. Identification of a new insulin-binding domain in the insulin receptor.
Kurose T; Pashmforoush M; Yoshimasa Y; Carroll R; Schwartz GP; Burke GT; Katsoyannis PG; Steiner DF
J Biol Chem; 1994 Nov; 269(46):29190-7. PubMed ID: 7961885
[TBL] [Abstract][Full Text] [Related]
9. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
10. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin.
Tager H; Thomas N; Assoian R; Rubenstein A; Saekow M; Olefsky J; Kaiser ET
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3181-5. PubMed ID: 6997872
[TBL] [Abstract][Full Text] [Related]
11. Structural integrity of the B24 site in human insulin is important for hormone functionality.
Žáková L; Kletvíková E; Veverka V; Lepsík M; Watson CJ; Turkenburg JP; Jirácek J; Brzozowski AM
J Biol Chem; 2013 Apr; 288(15):10230-40. PubMed ID: 23447530
[TBL] [Abstract][Full Text] [Related]
12. Shortened insulin with enhanced in vitro potency.
Casaretto M; Spoden M; Diaconescu C; Gattner HG; Zahn H; Brandenburg D; Wollmer A
Biol Chem Hoppe Seyler; 1987 Jun; 368(6):709-16. PubMed ID: 3304338
[TBL] [Abstract][Full Text] [Related]
13. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
14. Implications of replacing peptide bonds in the COOH-terminal B chain domain of insulin by the psi (CH2-NH) linker.
Nakagawa SH; Johansen NL; Madsen K; Schwartz TW; Tager HS
Int J Pept Protein Res; 1993 Dec; 42(6):578-84. PubMed ID: 8307689
[TBL] [Abstract][Full Text] [Related]
15. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of invariant valine B12 in insulin: implications for receptor binding.
Nakagawa SH; Tager HS; Steiner DF
Biochemistry; 2000 Dec; 39(51):15826-35. PubMed ID: 11123908
[TBL] [Abstract][Full Text] [Related]
17. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin.
Fischer WH; Saunders D; Brandenburg D; Diaconescu C; Wollmer A; Dodson G; De Meyts P; Zahn H
Biol Chem Hoppe Seyler; 1986 Sep; 367(9):999-1006. PubMed ID: 3539147
[TBL] [Abstract][Full Text] [Related]
18. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine.
Du H; Shi J; Cui D; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):133-9. PubMed ID: 18235975
[TBL] [Abstract][Full Text] [Related]
19. Implications of invariant residue LeuB6 in insulin-receptor interactions.
Nakagawa SH; Tager HS
J Biol Chem; 1991 Jun; 266(18):11502-9. PubMed ID: 2050662
[TBL] [Abstract][Full Text] [Related]
20. The role of the C-terminus of the insulin B-chain in modulating structural and functional properties of the hormone.
Leyer S; Gattner HG; Leithäuser M; Brandenburg D; Wollmer A; Höcker H
Int J Pept Protein Res; 1995 Nov; 46(5):397-407. PubMed ID: 8567184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
